John Kapoor, Petitioner v. United States

Track this case

Case Number:

21-994

Court:

Supreme Court

Nature of Suit:

Firms

  1. June 13, 2022

    Justices Spurn Insys Exec's Appeal In Landmark Opioid Case

    The U.S. Supreme Court said Monday it would not hear an appeal by John Kapoor, the founder of Insys Therapeutics Inc., challenging his conviction for orchestrating a scheme to bribe doctors to prescribe a powerful opioid spray.

  2. May 16, 2022

    Insys Founder Says Looming Opioid Ruling Boosts Appeal

    The founder of Insys Therapeutics Inc. told the U.S. Supreme Court that a pending high court ruling could undo his conviction for orchestrating a scheme to bribe doctors to prescribe a powerful opioid spray.

  3. January 25, 2022

    The Insys Case Made History. Why An Exec's Appeal May Not

    Insys Therapeutics Inc.'s founder has asked the U.S. Supreme Court to hear his appeal after being convicted of orchestrating a scheme to bribe doctors to prescribe opioids, a landmark case that rested on novel legal theories but may not pique the justices' interest.

  4. January 14, 2022

    Insys Founder Challenges Opioid Conviction At High Court

    A former Insys Therapeutics executive wants the U.S. Supreme Court to take a look at his conviction for allegedly scheming to bribe doctors to prescribe opioids, saying the case is a way to clear up an important question regarding relationships between non-physicians and physicians.